Sysnav Healthcare and Roche have collaborated to develop industry-standard outcome measures for disorders related to movement disorders and to design next-generation wearable technologies based on Sysnav technology.
Patients with neuromuscular disorders often experience movement impairments that fundamentally affect their daily lives. Reliable, objective measurements of changes in a patient’s motor function can help physicians prescribe the most appropriate treatment options and support research aimed at developing new drugs that improve lives.
Sysnav Healthcare develops medical-grade wearables based on magnetic-inertial technology for 3D motion reconstruction. This enables precise motion tracking without GPS, enabling indoor monitoring while preserving patient privacy. Sysnav has worked closely with academic collaborators, patient associations and Roche to obtain the first European Medicines Agency qualification for a digital endpoint (SV95c) for Duchenne muscular dystrophy.
Sysnav and Roche have expanded their collaboration across multiple projects to develop meaningful digital endpoints that will monitor disease progression, support clinical trials and serve as regulator-approved outcome measures.
The partnership will also develop next-generation wearable technology to further advance personalized healthcare.
Measuring Disease Progression
“Sysnav’s technology offers the opportunity to measure the progression of functional disease to a range of disease regulatory criteria. This has the potential to improve the way patients participate in clinical research, the ability to identify potential therapeutic benefits, and enrich our understanding of disease pathophysiology,” said James Sabry, Global Head of Pharmaceutical Partnerships, Roche.
“When high-precision technology meets clinical expertise, it is a game-changing combination that can accelerate medical progress. Combining Sysnav’s digital health technology with Roche’s expertise in neuroscience drug development and personalized medicine, will allow us to make a real and meaningful impact on people with movement disorders. By establishing a new industry standard for sports injury assessment, we can unlock innovation for the benefit of all patients,” said Damien Eggenspieler, Program Director, Sysnav Healthcare.
About Sysnav Healthcare
Sysnav Healthcare is a business unit of the French technology company Sysnav. Since the beginning of the event, Sysnav Healthcare has aimed to unlock the potential of real data in the medical field by adapting motion capture solutions to meet the needs of healthcare professionals and patients.
The company has developed two wearable devices, ActiMyo and Syde.